Publikationen (44) Publikationen von Paula Aranaz Oroz

2024

  1. Anti-Obesity Effects of a Collagen with Low Digestibility and High Swelling Capacity: A Human Randomized Control Trial

    Nutrients , Vol. 16, Núm. 20

  2. Application of Gut Bacterial Profiling Information in Precision Nutrition for Obesity and Weight Loss Management

    Lifestyle genomics, Vol. 17, Núm. 1, pp. 22-30

  3. Caenorhabditis elegans as a Screening Model for Probiotics with Properties against Metabolic Syndrome

    International Journal of Molecular Sciences, Vol. 25, Núm. 2

  4. Health Effects and Mechanisms of Inulin Action in Human Metabolism

    Nutrients , Vol. 16, Núm. 17

  5. MicroRNAs from edible plants reach the human gastrointestinal tract and may act as potential regulators of gene expression

    Journal of Physiology and Biochemistry, Vol. 80, Núm. 3, pp. 655-670

  6. Plant miR6262 Modulates the Expression of Metabolic and Thermogenic Genes in Human Hepatocytes and Adipocytes

    Nutrients , Vol. 16, Núm. 18

  7. Plant miR8126-3p and miR8126-5p Decrease Lipid Accumulation through Modulation of Metabolic Genes in a Human Hepatocyte Model That Mimics Steatosis

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

  8. Polyphenols and metabolism: from present knowledge to future challenges

    Journal of Physiology and Biochemistry, Vol. 80, Núm. 3, pp. 603-625

2023

  1. Gliadin nanoparticles for oral administration of bioactives: Ex vivo and in vivo investigations

    International Journal of Biological Macromolecules, Vol. 249

  2. Glucose-lowering effects of a synbiotic combination containing Pediococcus acidilactici in C. elegans and mice

    Diabetologia, Vol. 66, Núm. 11, pp. 2117-2138

  3. Pediococcus acidilactici (pA1c®) alleviates obesity-related dyslipidemia and inflammation in Wistar rats by activating beta-oxidation and modulating the gut microbiota

    Food and Function, Vol. 14, Núm. 24, pp. 10855-10867

2022

  1. Pediococcus acidilactici CECT9879 (pA1c) Counteracts the Effect of a High‐Glucose Exposure in C. elegans by Affecting the Insulin Signaling Pathway (IIS)

    International Journal of Molecular Sciences, Vol. 23, Núm. 5

2021

  1. A predictive regression model of the obesity-related inflammatory status based on gut microbiota composition

    International Journal of Obesity, Vol. 45, Núm. 10, pp. 2261-2268

  2. Bioactive extracts from persimmon waste: Influence of extraction conditions and ripeness

    Food and Function, Vol. 12, Núm. 16, pp. 7428-7439

  3. Diet- and sex-related changes of gut microbiota composition and functional profiles after 4 months of weight loss intervention

    European Journal of Nutrition, Vol. 60, Núm. 6, pp. 3279-3301

  4. Grifola frondosa (Maitake) extract reduces fat accumulation and improves health span in c. elegans through the daf-16/foxo and skn-1/nrf2 signalling pathways

    Nutrients, Vol. 13, Núm. 11

  5. Gut microbiota differences according to ultra-processed food consumption in a spanish population

    Nutrients, Vol. 13, Núm. 8

  6. In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions

    Acta Pharmaceutica Sinica B, Vol. 11, Núm. 4, pp. 989-1002

  7. Potential Mechanisms Linking Food-Derived MicroRNAs, Gut Microbiota and Intestinal Barrier Functions in the Context of Nutrition and Human Health

    Frontiers in Nutrition, Vol. 8

  8. Test metagenómicos y de disbiosis: presente y futuro

    Revista española de nutrición humana y dietética, Vol. 25, Núm. 3, pp. 20-21